What is Global Travel Sickness Drugs Market?
The Global Travel Sickness Drugs Market is a specialized sector within the pharmaceutical industry that focuses on the development and distribution of medications designed to prevent and treat motion sickness. This condition, also known as travel sickness, can occur during any form of travel, including by car, boat, plane, or train. Symptoms typically include nausea, vomiting, dizziness, and a general feeling of unwellness. The market for these drugs is global in nature, as travel sickness is a universal issue that affects people regardless of their geographical location or cultural background. The market is driven by various factors, including the increasing prevalence of travel sickness, advancements in drug development, and the growing global travel industry. The market includes both prescription and over-the-counter medications, catering to a wide range of consumer needs and preferences.
Anticholinergic, Antihistamines, Others in the Global Travel Sickness Drugs Market:
The Global Travel Sickness Drugs Market is segmented based on the type of drugs, which include Anticholinergic, Antihistamines, and others. Anticholinergic drugs work by blocking the action of acetylcholine, a neurotransmitter that transmits signals in the nervous system. By doing this, they can help to reduce the symptoms of motion sickness. Antihistamines, on the other hand, work by blocking the action of histamine, a chemical in the body that can cause symptoms of allergy and motion sickness. Other types of travel sickness drugs include those that work by affecting the balance centers in the inner ear, and those that work by calming the stomach. Each of these types of drugs has its own advantages and disadvantages, and the choice of which to use often depends on the individual's specific symptoms and overall health condition.
Adults, Children in the Global Travel Sickness Drugs Market:
The usage of Global Travel Sickness Drugs varies between adults and children. For adults, the drugs are often used to prevent and treat motion sickness during long-distance travel, such as on airplanes or cruise ships. They can also be used by those who experience motion sickness during shorter trips, such as car rides. For children, the drugs are typically used to prevent and treat motion sickness during family vacations or school trips. It's important to note that not all travel sickness drugs are suitable for children, and parents should always consult with a healthcare professional before giving these medications to their children.
Global Travel Sickness Drugs Market Outlook:
Looking at the market outlook for the Global Travel Sickness Drugs Market, it was valued at US$ 394 million in 2023. It is projected to reach a value of US$ 482 million by 2030, growing at a compound annual growth rate (CAGR) of 2.9% during the forecast period from 2024 to 2030. This growth is set against the backdrop of the global pharmaceutical market, which was worth 1475 billion USD in 2022 and is expected to grow at a CAGR of 5% over the next six years. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. These figures highlight the significant potential for growth within the travel sickness drugs market, driven by factors such as increasing global travel and advancements in drug development.
| Report Metric | Details |
| Report Name | Travel Sickness Drugs Market |
| Accounted market size in 2023 | US$ 394 million |
| Forecasted market size in 2030 | US$ 482 million |
| CAGR | 2.9% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Viatris, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
